Evidence-Based Clinical Review  |   August 2016
Ophthalmic Diseases in Patients With Obstructive Sleep Apnea
Author Notes
  • From the Mayo Clinic Health System in Albert Lea, Minnesota (Dr Skorin), and Art of Optiks in Edina, Minnesota (Dr Knutson). Dr Skorin holds a master’s degree in medical education leadership. 
  •  *Address correspondence to Leonid Skorin Jr, DO, OD, MS, Mayo Clinic Health System, 404 W Fountain St, Albert Lea, MN 56007-2437. E-mail: skorin.leonid@mayo.edu
     
Article Information
Cardiovascular Disorders / Emergency Medicine / Evidence-Based Medicine / Neuromusculoskeletal Disorders / Ophthalmology and Otolaryngology / Sleep Medicine
Evidence-Based Clinical Review   |   August 2016
Ophthalmic Diseases in Patients With Obstructive Sleep Apnea
The Journal of the American Osteopathic Association, August 2016, Vol. 116, 522-529. doi:10.7556/jaoa.2016.105
The Journal of the American Osteopathic Association, August 2016, Vol. 116, 522-529. doi:10.7556/jaoa.2016.105
Abstract

Symptomatic obstructive sleep apnea (OSA) affects 2% of women and 4% of men, but the prevalence of asymptomatic OSA is significantly higher. Several ophthalmic conditions are associated with OSA, including floppy eyelid syndrome, glaucoma, nonarteritic anterior ischemic optic neuropathy, papilledema, keratoconus, and central serous chorioretinopathy. The purpose of this review is to provide primary care physicians with a general knowledge of the signs, symptoms, and management of the ophthalmic diseases associated with OSA.

Subscribe to view more

For full access to this article, log in to an existing user account, purchase an annual subscription, or purchase a short-term subscription.

Order a subscription

Subscribe

Pay Per View

Entire Journal
30-Day Access

$30.00

Buy Now

This Issue
7-Day Access

$15.00

Buy Now

This article
24-Hour Access

$5.00

Buy Now

Sign In Or Create an account

Please sign in using your Osteopathic.org login.
If you do not have an AOA login, you may create a new account.

Or Subscribe